0001645113-24-000015.txt : 20240520 0001645113-24-000015.hdr.sgml : 20240520 20240520080117 ACCESSION NUMBER: 0001645113-24-000015 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240520 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 24962388 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 8-K 1 nvcr-20240520.htm 8-K nvcr-20240520
0001645113false00016451132024-03-012024-05-03


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

May 20, 2024
Date of Report (date of earliest event reported)

NovoCure Limited
(Exact name of registrant as specified in its charter)
Jersey
001-37565
98-1057807
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
No. 4 The Forum, Grenville Street
St. Helier
Jersey
JE2 4UF
(Address of Principal Executive Offices)
(Zip Code)
+44 (0) 15 3475 6700
Registrant's telephone number, including area code

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Ordinary Shares, no par valueNVCRThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o



Item 7.01 Regulation FD Disclosure

The abstract of the results of NovoCure Limited's ("Novocure") METIS phase 3 clinical trial in brain metastases from non-small cell lung cancer to be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago will be made available on the ASCO website as a regular abstract on Thursday, May 23, 2024, at 5:00 PM (EDT). The METIS data will be presented on June 3, 2024, at 10:24 AM (CDT), during ASCO’s Central Nervous System Tumors session.

The information contained in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits

(d)    Exhibits
Exhibit No.Description
104Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NovoCure Limited
(Registrant)

Date: May 20, 2024


By: /s/ Ashley Cordova  
Name: Ashley Cordova
Title: Chief Financial Officer

 EX-101.SCH 2 nvcr-20240520.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 nvcr-20240520_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Country Entity Address, Country Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Security Exchange Name Security Exchange Name Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Postal Zip Code Entity Address, Postal Zip Code Cover [Abstract] Cover [Abstract] Written Communications Written Communications Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security City Area Code City Area Code Document Period End Date Document Period End Date Entity Tax Identification Number Entity Tax Identification Number Amendment Flag Amendment Flag Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Pre-commencement Tender Offer Pre-commencement Tender Offer Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 nvcr-20240520_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document and Entity Information Document
 2 Months Ended
May 03, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date May 20, 2024
Entity Registrant Name NovoCure Limited
Entity Central Index Key 0001645113
Amendment Flag false
Entity Incorporation, State or Country Code Y9
Entity File Number 001-37565
Entity Tax Identification Number 98-1057807
Entity Address, Address Line One No. 4 The Forum, Grenville Street
Entity Address, City or Town St. Helier
Entity Address, Country JE
Entity Address, Postal Zip Code JE2 4UF
City Area Code 44 (0) 15
Local Phone Number 3475 6700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Ordinary Shares, no par value
Trading Symbol NVCR
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Document and Entity Information Document Sheet http://www.novocure.com/role/DocumentandEntityInformationDocument Document and Entity Information Document Cover 1 false false All Reports Book All Reports nvcr-20240520.htm nvcr-20240520.xsd nvcr-20240520_lab.xml nvcr-20240520_pre.xml http://xbrl.sec.gov/dei/2024 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "nvcr-20240520.htm": { "nsprefix": "nvcr", "nsuri": "http://www.novocure.com/20240520", "dts": { "inline": { "local": [ "nvcr-20240520.htm" ] }, "schema": { "local": [ "nvcr-20240520.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd" ] }, "labelLink": { "local": [ "nvcr-20240520_lab.xml" ] }, "presentationLink": { "local": [ "nvcr-20240520_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 22 }, "report": { "R1": { "role": "http://www.novocure.com/role/DocumentandEntityInformationDocument", "longName": "0000001 - Document - Document and Entity Information Document", "shortName": "Document and Entity Information Document", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvcr-20240520.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvcr-20240520.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Country", "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 14 0001645113-24-000015-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001645113-24-000015-xbrl.zip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end XML 16 nvcr-20240520_htm.xml IDEA: XBRL DOCUMENT 0001645113 2024-03-01 2024-05-03 0001645113 false 8-K 2024-05-20 NovoCure Limited Y9 001-37565 98-1057807 No. 4 The Forum, Grenville Street St. Helier JE JE2 4UF 44 (0) 15 3475 6700 false false false false Ordinary Shares, no par value NVCR NASDAQ false